ReviewJournal of extracellular vesicles2026
Natural Product-Derived Vesicles in Nanotherapeutics.
Review in Journal of extracellular vesicles, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Natural product-derived vesicles (NPVs) are lipid bilayer-enclosed nanovesicles isolated from diverse sources, including plants, fungi, and marine organisms, and are increasingly recognized as an emerging class of extracellular vesicles with potential therapeutic relevance. Their abundance, renewability, and capacity to transport endogenous metabolites and exogenous cargoes highlight their potential as scalable biological delivery vehicles. NPVs can interact with mammalian cells, participate in intercellular communication, and influence conserved biological pathways that modulate disease, support tissue repair, and maintain cellular homeostasis. In addition, their structural plasticity provides opportunities for physicochemical optimization to improve functional performance and targeting properties. However, the development and translation of NPVs are constrained by challenges, including heterogeneity, variability in isolation procedures, and insufficient physicochemical and functional characterization. This review presents a systematic framework encompassing source identification, purification strategies, and characterization methods, while integrating separation approaches with multifaceted assessments to facilitate the rational development of NPVs, with particular emphasis on recent advances in structural optimization and therapeutic efficacy. Furthermore, the status of nine clinical trials is highlighted, reflecting the growing translational and therapeutic potential of NPVs. By delineating current limitations and discussing potential solutions, this review provides practical guidance for improving the physicochemical consistency and biological performance of NPVs, thereby facilitating their development as nature-inspired nanotherapeutic systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.